发明授权
US08226951B2 Methods for treating bone cancer by administering a nerve growth factor antagonist antibody
有权
通过施用神经生长因子拮抗剂抗体治疗骨癌的方法
- 专利标题： Methods for treating bone cancer by administering a nerve growth factor antagonist antibody
- 专利标题（中）： 通过施用神经生长因子拮抗剂抗体治疗骨癌的方法
-
申请号： US13153587申请日： 2011-06-06
-
公开(公告)号： US08226951B2公开(公告)日： 2012-07-24
- 发明人: David L. Shelton , Patrick William Mantyh
- 申请人： David L. Shelton , Patrick William Mantyh
- 申请人地址： US NY New York
- 专利权人： Pfizer Inc.
- 当前专利权人： Pfizer Inc.
- 当前专利权人地址： US NY New York
- 代理机构： Pfizer Inc.
- 主分类号： A61K39/395
- IPC分类号： A61K39/395 ; C07K16/22 ; C12P21/08
摘要：
The invention features methods and compositions for preventing or treating bone cancer pain including cancer pain associated with bone metastasis by administering an antagonist of nerve growth factor (NGF). The NGF antagonist may be an anti-NGF (such as anti-hNGF) antibody that is capable of binding hNGF.
公开/授权文献
信息查询
